The result of the study found p53 expression in 24.4% of non-oropharyngeal HNSCC, which is lower than 64% reported Nylander et al., [35] but similar to findings from previous studies [36, 37]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.